License Control for Salesforce from Aspera enables cloud cost optimization.Aachen/Berlin, Germany, September 26, 2017 - Last night in Berlin, Novartis, the Swiss pharmaceutical group and a client of Aspera, was awarded 1st place in the "Tool/Software" category for developing an innovative license-management solution for optimizing Salesforce licenses. Novartis AG is one of the largest pharmaceutical companies in the world, with around $49 billion in sales in 2016.The goal of the "Cloud SAM for Salesforce" project...
Source: RealWire
- View Press Release
|
|
|
